Osteoporosis, bone & mineral

Serum Klotho Modifies the Associations of 25-Hydroxy Vitamin D With All-Cause and Cardiovascular Mortality

J Clin Endocrinol MetabPublished Cohort study

Authors' conclusion

Vitamin D-associated mortality risk is observed only with concurrently decreasing klotho, indicating that vitamin D metabolism dysfunction increases the risk of mortality. Klotho levels could help predict long-term mortality outcomes and thus may be useful concurrently for guiding vitamin D supplementation therapy decision-making in populations with vitamin D deficiency.

Study context

Population
American community-dwelling adults, NHANES 2007–2016
Participants
9,870 adults
Exposure
Joint association of serum 25D and klotho with mortality
Outcome
All-cause and CVD mortality
Methodological detailsNHANES 2007-2016, linked to National Death Index, Cox proportional hazards models
  • NHANES 2007-2016
  • Linked to National Death Index
  • Cox proportional hazards models

Main finding

As reported in the abstract

Interaction of klotho and serum 25(OH)D on all-cause and CVD mortality
Interaction between klotho and serum 25(OH)D in all-cause mortality
P = .028
Klotho < 848.4 pg/mL, serum 25(OH)D < 50 nmol/L: all-cause mortality HR
1.36 (1.10-1.69) (95% CI)
Klotho < 848.4 pg/mL, serum 25(OH)D < 50 nmol/L: Cardiovascular disease (CVD) mortality HR
1.78 (1.16-3.45) (95% CI)
Klotho < 848.4 pg/mL, continuous serum 25(OH)D: all-cause mortality HR
0.98 (.97-.99) (95% CI)
Klotho < 848.4 pg/mL, continuous serum 25(OH)D: CVD mortality HR
0.98 (.98-.99) (95% CI)

Observational data: associations, not effects.

Further findings

Combined serum 25(OH)D <50 nmol/L and klotho <848.4 pg/mL (vitamin D metabolism disruption)

All-cause mortality HR
1.48 (1.11-1.96) (95% CI)
CVD mortality HR
2.36 (1.48-3.75) (95% CI)

Original publication

Serum Klotho Modifies the Associations of 25-Hydroxy Vitamin D With All-Cause and Cardiovascular Mortality. J Clin Endocrinol Metab. Published 15 August 2023. doi:10.1210/clinem/dgad480

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.